What Is 10-Deacetylbaccatin III

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 11, 2026

Quick Answer: 10-Deacetylbaccatin III is a natural alkaloid compound with molecular formula C29H36O10 isolated from yew trees (Taxus baccata), serving as a critical precursor in the semi-synthesis of paclitaxel (Taxol), a widely used chemotherapy drug. This intermediate is enzymatically converted to baccatin III through acetylation, a key step in producing one of the world's most important anticancer medications.

Key Facts

10-Deacetylbaccatin III has the chemical formula C29H36O10 and is isolated from European yew tree needles and branches
It is converted to baccatin III by the enzyme 10-deacetylbaccatin III-10-β-O-acetyltransferase (DBAT) in four steps to produce paclitaxel
Semi-synthesis of paclitaxel from 10-DAB has become a major clinical supply source for the $1.5+ billion Taxol market
The compound exhibits antileishmanial activity and can inhibit microtubule disassembly, triggering cell cycle arrest and apoptosis
Enzymatic conversion methods for 10-DAB are more selective, efficient, and environmentally friendly than conventional chemical synthesis

Overview

10-Deacetylbaccatin III (10-DAB) is a naturally occurring alkaloid with the molecular formula C29H36O10, obtained from the needles and small branches of the European yew tree (Taxus baccata). This complex polycyclic compound features a tetracyclic taxane skeleton with multiple hydroxyl groups and an acetoxy functional group, making it a highly structured and bioactive molecule. The compound appears as a white to almost-white crystalline powder and is characterized by specific optical properties, with typical optical rotation values ranging from -40.0 to -44.0 degrees.

The primary significance of 10-deacetylbaccatin III lies in its role as an advanced precursor in pharmaceutical synthesis. Rather than extracting paclitaxel directly from natural sources, which is labor-intensive and environmentally challenging, manufacturers use 10-DAB as the starting material for semi-synthetic production. This approach dramatically increased the availability of paclitaxel (Taxol), one of the most important chemotherapy drugs globally, while reducing pressure on endangered yew tree populations and improving production efficiency.

How It Works

10-Deacetylbaccatin III undergoes a series of chemical transformations to become paclitaxel through enzymatic and chemical processes:

Acetylation Step: The first critical transformation converts 10-DAB to baccatin III through C10-hydroxyl acetylation, catalyzed by the enzyme 10-deacetylbaccatin III-10-β-O-acetyltransferase (DBAT), which adds an acetyl group at a specific hydroxyl position
Enzymatic Conversion: DBAT enzyme exhibits high selectivity and efficiency, converting 10-DAB directly to baccatin III with superior regioselectivity compared to chemical methods, resulting in purer products with fewer side reactions
Regioselective Protection: The synthesis process includes regioselective protection of the hydroxyl group at C-7 of 10-DAB III to prevent unwanted side reactions and ensure the final product's correct structure
Multi-Step Semi-Synthesis: From baccatin III, an additional side chain is attached through a complex organic synthesis pathway spanning approximately four to five total steps from the initial 10-DAB precursor to yield the final paclitaxel molecule
Biocatalytic Advantages: Enzymatic conversion methods for 10-DAB demonstrate superior selectivity, higher efficiency, and more eco-friendly processing compared to purely chemical synthetic routes, making industrial-scale production more sustainable

Key Comparisons

Compound	Molecular Formula	Role in Taxol Synthesis	Source
10-Deacetylbaccatin III	C29H36O10	Initial precursor; starting material for semi-synthesis	Taxus baccata yew tree needles
Baccatin III	C31H38O11	Intermediate product; one acetyl group added to 10-DAB	Synthesized from 10-DAB via DBAT enzyme
Paclitaxel (Taxol)	C47H51NO14	Final active pharmaceutical compound; anticancer drug	Synthesized from baccatin III with side chain attachment
Docetaxel (Taxotere)	C43H53NO14	Alternative taxane drug with similar mechanism	Also synthesized from 10-DAB precursor

Why It Matters

Cancer Treatment Revolution: 10-Deacetylbaccatin III enabled the mass production of paclitaxel, revolutionizing chemotherapy by providing a sustainable supply of this highly effective anticancer agent used in treating lung, breast, and ovarian cancers
Environmental Protection: Semi-synthetic production from 10-DAB dramatically reduced the need for harvesting wild yew trees, which grow slowly and are threatened by overharvesting, allowing natural populations to recover
Economic Impact: The paclitaxel market exceeds $1.5 billion annually, and efficient production from 10-DAB precursors makes treatment accessible to millions of patients worldwide at reasonable costs
Biological Activity: Beyond its pharmaceutical role, 10-DAB exhibits direct antileishmanial properties and can inhibit microtubule disassembly, making it valuable for studying cellular mechanisms and potential additional therapeutic applications
Biotechnology Innovation: Research into improving DBAT enzyme efficiency continues to enhance production yields and reduce manufacturing costs, representing ongoing advances in biocatalysis and green chemistry

The discovery and application of 10-deacetylbaccatin III as a pharmaceutical precursor represents a landmark achievement in medicinal chemistry. By identifying this advanced precursor in readily available yew trees and developing efficient methods to convert it into paclitaxel, pharmaceutical scientists solved critical supply chain challenges and enabled millions of cancer patients to access life-saving treatment. Continued improvements in enzymatic conversion methods promise even more efficient, sustainable, and cost-effective production in the coming years.